Asebio and Invest in Bogota present Biolatam, a meeting point for biotechnology in Latin America

By Biocat

The Spanish Association of Biotechnology Companies (Asebio) and the public-private agency Invest in Bogota, with collaboration from various organizations in Spain and Colombia including Biocat, are holding the Biolatam Partnering & Conference on 9 and 10 December 2013 in Bogota.

Biolatam was created with the aim of positioning itself as the leading event in Latin America to foster business development among biotechnology, pharmaceutical, medical technology, food, veterinary and energy companies, investors, institutions and research centers with interests in this market.

Noteworthy data (to be confirmed):

• More than 500 participants, with good turnout from the United States, Latin America and Europe, as well as other significant markets for biotechnology like Japan, Israel and Canada.
• Participation of more than 20 international capital funds.
• Partnering module featuring PartneringOne software by EBD Group (organizer of benchmark congresses in the life sciences arena including BIO-Europe, BioPharm America, Biospain...).
• Program of conferences on bioeconomy and biofuel, advanced therapies, food biotechnology, personalized medicine, healthcare products and venture capital. 

So far, more than 60 companies from Spain, Colombia, Brazil, the United States, Chile, Mexico, and Costa Rica, among others, have confirmed their participation.

Registration is now open and the rates are as follows (per person):

• General registration: €400 (taxes not included)
• Asebio members and Colombian SMEs: €200 (taxes not included)

Companies and organizations receiving this e-mail are eligible for a 25% discount (off the general registration rate) through 31 August. Just enter "Biocat Member" in the "Comments" field when registering.

Questions:
Asebio (Esther Campos / David Fernández)
Tel. +34 912 109 374
biolatam2013@biolatam.org

Organized by:	Collaborators: